210 related articles for article (PubMed ID: 15173839)
1. Targeted therapy for brain tumours.
Lesniak MS; Brem H
Nat Rev Drug Discov; 2004 Jun; 3(6):499-508. PubMed ID: 15173839
[No Abstract] [Full Text] [Related]
2. Chemotherapy and targeted molecular therapies for brain metastases.
Drappatz J; Wen PY
Expert Rev Neurother; 2006 Oct; 6(10):1465-79. PubMed ID: 17078787
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery to brain tumours: challenges and progress.
Ningaraj NS
Expert Opin Drug Deliv; 2006 Jul; 3(4):499-509. PubMed ID: 16822225
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for brain tumors with polymer drug delivery.
Attenello F; Raza SM; Dimeco F; Olivi A
Handb Clin Neurol; 2012; 104():339-53. PubMed ID: 22230452
[No Abstract] [Full Text] [Related]
5. Emerging targeted treatments for malignant glioma.
Mulholland PJ; Thirlwell C; Brock CS; Newlands ES
Expert Opin Emerg Drugs; 2005 Nov; 10(4):845-54. PubMed ID: 16262566
[TBL] [Abstract][Full Text] [Related]
6. Chemistry: dendrimers set to self-destruct.
Meijer EW; Van Genderen MH
Nature; 2003 Nov; 426(6963):128-9. PubMed ID: 14614485
[No Abstract] [Full Text] [Related]
7. Local delivery of antineoplastic agents by controlled-release polymers for the treatment of malignant brain tumours.
Raza SM; Pradilla G; Legnani FG; Thai QA; Olivi A; Weingart JD; Brem H
Expert Opin Biol Ther; 2005 Apr; 5(4):477-94. PubMed ID: 15934827
[TBL] [Abstract][Full Text] [Related]
8. Magnetically targeted nanoparticles for brain tumor therapy: what does the future hold?
David AE; Cole AJ; Yang VC
Nanomedicine (Lond); 2011 Sep; 6(7):1133-5. PubMed ID: 21929450
[No Abstract] [Full Text] [Related]
9. Advances in strategies to improve drug delivery to brain tumors.
Newton HB
Expert Rev Neurother; 2006 Oct; 6(10):1495-509. PubMed ID: 17078789
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles of biodegradable polymers for new-concept chemotherapy.
Feng SS
Expert Rev Med Devices; 2004 Sep; 1(1):115-25. PubMed ID: 16293015
[TBL] [Abstract][Full Text] [Related]
11. Convection-enhanced delivery: targeted toxin treatment of malignant glioma.
Hall WA; Sherr GT
Neurosurg Focus; 2006 Apr; 20(4):E10. PubMed ID: 16709015
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle and targeted systems for cancer therapy.
Brannon-Peppas L; Blanchette JO
Adv Drug Deliv Rev; 2004 Sep; 56(11):1649-59. PubMed ID: 15350294
[TBL] [Abstract][Full Text] [Related]
13. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
Juillerat-Jeanneret L
Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
[TBL] [Abstract][Full Text] [Related]
14. Supramolecular drug-delivery systems based on polymeric core-shell architectures.
Haag R
Angew Chem Int Ed Engl; 2004 Jan; 43(3):278-82. PubMed ID: 14705079
[No Abstract] [Full Text] [Related]
15. Dendrimers and dendritic polymers in drug delivery.
Gillies ER; Fréchet JM
Drug Discov Today; 2005 Jan; 10(1):35-43. PubMed ID: 15676297
[TBL] [Abstract][Full Text] [Related]
16. Local drug delivery to the brain.
Wang PP; Frazier J; Brem H
Adv Drug Deliv Rev; 2002 Oct; 54(7):987-1013. PubMed ID: 12384318
[TBL] [Abstract][Full Text] [Related]
17. Brain tumors: controversies and challenges in management.
Lesniak MS
Expert Rev Neurother; 2005 Nov; 5(6 Suppl):1-2. PubMed ID: 16274264
[No Abstract] [Full Text] [Related]
18. Use of nanoparticles for drug delivery in glioblastoma multiforme.
Jain KK
Expert Rev Neurother; 2007 Apr; 7(4):363-72. PubMed ID: 17425491
[TBL] [Abstract][Full Text] [Related]
19. Drug cocktails for effective treatment of glioblastoma multiforme.
Debinski W
Expert Rev Neurother; 2008 Apr; 8(4):515-7. PubMed ID: 18416653
[No Abstract] [Full Text] [Related]
20. Targeted therapy for neuro-oncology: reviewing the menu.
Lampson LA
Drug Discov Today; 2009 Feb; 14(3-4):185-91. PubMed ID: 19063992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]